Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated:  12/13/2017
Clinical Research Facility
mi
from
Houston, TX
Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated: 12/13/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated:  12/13/2017
Clinical Research Facility
mi
from
McAllen, TX
Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated: 12/13/2017
Clinical Research Facility
mi
from
McAllen, TX
Click here to add this to my saved trials
Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated:  12/13/2017
mi
from
Asenovgrad,
Study of VIS410 in Subjects With Uncomplicated Influenza A
A Phase 2a Double-blind, Placebo-controlled Study to Assess the Safety and Tolerability of a Single Intravenous Dose of VIS410 in Subjects With Uncomplicated Influenza A Infection
Status: Enrolling
Updated: 12/13/2017
mi
from
Asenovgrad,
Click here to add this to my saved trials
The Effect of Proximity on Flu-Shot Participation
The Effect of Proximity on Flu-Shot Participation
Status: Enrolling
Updated:  12/14/2017
Express Scripts
mi
from
Saint Louis, MO
The Effect of Proximity on Flu-Shot Participation
The Effect of Proximity on Flu-Shot Participation
Status: Enrolling
Updated: 12/14/2017
Express Scripts
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Testing the AVI-7100 Flu Drug in Healthy Volunteers
A Phase 1, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects
Status: Enrolling
Updated:  12/22/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Testing the AVI-7100 Flu Drug in Healthy Volunteers
A Phase 1, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects
Status: Enrolling
Updated: 12/22/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)
A Phase IA/IB Trial to Evaluate the Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) With Hemagglutinin Dose Escalation Compared to Non-Adjuvanted Comparator Inactivated Influenza Vaccine (IIV) Standard Dose (SD) in Healthy Adults and High Dose (HD) IIV in Ambulatory Elderly Subjects
Status: Enrolling
Updated:  1/26/2018
Saint Louis University School of Medicine
mi
from
Saint Louis, MO
The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)
A Phase IA/IB Trial to Evaluate the Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) With Hemagglutinin Dose Escalation Compared to Non-Adjuvanted Comparator Inactivated Influenza Vaccine (IIV) Standard Dose (SD) in Healthy Adults and High Dose (HD) IIV in Ambulatory Elderly Subjects
Status: Enrolling
Updated: 1/26/2018
Saint Louis University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Clinical Performance of the Diassess Influenza A and B Test
Clinical Performance of the Diassess Influenza A and B Test
Status: Enrolling
Updated:  2/2/2018
University Health Care Center
mi
from
Syracuse, NY
Clinical Performance of the Diassess Influenza A and B Test
Clinical Performance of the Diassess Influenza A and B Test
Status: Enrolling
Updated: 2/2/2018
University Health Care Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
Clinical Immunization Safety Assessment (CISA): A Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine (IIV) Administered to Children 6 Through 47 Months of Age
Status: Enrolling
Updated:  2/5/2018
Duke University Health System
mi
from
Durham, NC
The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
Clinical Immunization Safety Assessment (CISA): A Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine (IIV) Administered to Children 6 Through 47 Months of Age
Status: Enrolling
Updated: 2/5/2018
Duke University Health System
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Milford, CT
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Milford, CT
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Coral Gables, FL
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Wichita, KA
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Rochester, NY
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Warwick, RI
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Nashville, TN
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
West Jordan, UT
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Saint Louis, MO
A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older
Safety and Immunogenicity Trial of High-Dose Quadrivalent Influenza Vaccine Administered by Intramuscular Route in Subjects Aged 65 Years and Older
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
San Diego, CA
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Miami, FL
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Albany, NY
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated:  2/5/2018
Clinical Research Facility
mi
from
Nashville, TN
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry Protocol
Status: Enrolling
Updated: 2/5/2018
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Fresno, CA
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Long Beach, CA
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Stanford, CA
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Atlantis, FL
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Atlantis, FL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Miami, FL
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Chicago, IL
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Detroit, MI
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Royal Oak, MI
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Troy, MI
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Troy, MI
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Minneapolis, MN
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Saint Louis, MO
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Teaneck, NJ
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Teaneck, NJ
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
Clinical Research Facility
mi
from
Houston, TX
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated:  2/8/2018
mi
from
Cairns,
A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult and Elderly Hospitalized Patients With Influenza A Infection
Status: Enrolling
Updated: 2/8/2018
mi
from
Cairns,
Click here to add this to my saved trials
PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
PregText: Assessing the Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
Status: Enrolling
Updated:  2/12/2018
Columbia University
mi
from
New York, NY
PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
PregText: Assessing the Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging
Status: Enrolling
Updated: 2/12/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Kent State University / Price Chopper Employee Wellness Study
Kent State University / Price Chopper Wellness Promotion Study
Status: Enrolling
Updated:  2/27/2018
The Golub Corporation (Price Chopper / Market 32)
mi
from
Schenectady, NY
Kent State University / Price Chopper Employee Wellness Study
Kent State University / Price Chopper Wellness Promotion Study
Status: Enrolling
Updated: 2/27/2018
The Golub Corporation (Price Chopper / Market 32)
mi
from
Schenectady, NY
Click here to add this to my saved trials
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated:  3/1/2018
University of Iowa - Vaccine Research & Education Unit
mi
from
Iowa City, IA
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated: 3/1/2018
University of Iowa - Vaccine Research & Education Unit
mi
from
Iowa City, IA
Click here to add this to my saved trials
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated:  3/1/2018
Saint Louis University - Center for Vaccine Development
mi
from
Saint Louis, MO
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated: 3/1/2018
Saint Louis University - Center for Vaccine Development
mi
from
Saint Louis, MO
Click here to add this to my saved trials
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated:  3/1/2018
Cincinnati Children's Hospital Medical Center - Infectious Diseases
mi
from
Cincinnati, OH
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated: 3/1/2018
Cincinnati Children's Hospital Medical Center - Infectious Diseases
mi
from
Cincinnati, OH
Click here to add this to my saved trials
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated:  3/1/2018
Baylor College of Medicine - Molecular Virology and Microbiology
mi
from
Houston, TX
H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults
A Phase I Randomized, Double-Blind, Controlled Trial in Healthy Adults to Assess the Safety, Reactogenicity, and Immunogenicity of a Monovalent Inactivated Influenza A/H5N8 Virus Vaccine Administered Intramuscularly at Different Dosages Given With or Without AS03 or MF59 Adjuvants
Status: Enrolling
Updated: 3/1/2018
Baylor College of Medicine - Molecular Virology and Microbiology
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Birmingham, AL
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Harrisburg, AR
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Harrisburg, AR
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Downey, CA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Downey, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Paramount, CA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Paramount, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
San Diego, CA
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Miami, FL
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated:  3/6/2018
Clinical Research Facility
mi
from
Meridian, ID
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age
Status: Enrolling
Updated: 3/6/2018
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials